Neutrophilia and NETopathy as Key Pathologic Drivers of Progressive Lung Impairment in Patients With COVID-19
Pharmacology
[키워드] Activation
acute respiratory distress
acute respiratory distress syndrome
alleviate
applied
approach
ARDS
Complication
COVID-19
curtail
degranulation
develop
elevated
exaggerated inflammatory response
fatal COVID-19
ill patient
immunopathology
inhibiting
manifestation
Mechanical
mechanical ventilation
morbidity
Mortality
multiple cytokines
NET
Neutrophil extracellular trap
Neutrophil extracellular traps
neutrophil recruitment
neutrophilia
Neutrophils
novel coronavirus disease
Pathogenesis
pathologic
patients
physical
Progressive
reduce
Respirator
SARS-CoV-2
severe complications
severely ill patient
Spread
survival
syndrome
tested
therapeutic strategy
Therapeutics
therapy
Treatment
with COVID-19
[DOI] 10.3389/fphar.2020.00870 PMC 바로가기 [Article Type] Pharmacology
[DOI] 10.3389/fphar.2020.00870 PMC 바로가기 [Article Type] Pharmacology